This study looks back at medical records to compare how well two existing drugs (telitacicept and belimumab) control lupus symptoms and how safe they are. Researchers will analyze data from 180 adults with moderate-to-severe lupus who were already taking one of these medications.…
Sponsor: Yipeng Liu • Aim: Disease control
Last updated Apr 01, 2026 22:56 UTC